LINC00673 rs11655237 C>T and susceptibility to Wilms tumor: A five‐center case–control study

Author:

Li Suhong1,Lin Ao2,Han Dandan1,Zhou Haixia3,Cheng Jiwen4,Zhang Jiao5,Fu Wen2,Zhuo Zhenjian2ORCID,He Jing2

Affiliation:

1. Department of PathologyChildren Hospital and Women Health Center of Shanxi Taiyuan Shannxi China

2. Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical CenterGuangzhou Medical University Guangzhou Guangdong China

3. Department of HematologyThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou Zhejiang China

4. Department of Pediatric Surgerythe Second Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi China

5. Department of Pediatric Surgerythe First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics(clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Reference44 articles.

1. Update on Wilms tumor

2. Epidemiology of Wilms tumor

3. Wilmsʼ tumor

4. Recent incidences and trends of childhood malignant solid tumors in Shanghai, 2002‐2010;Bao PP;Zhonghua Er Ke Za Zhi,2013

5. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3